Biotechnology Investment
-
Apollomics Announces Board Changes and Committee Composition
Apollomics (APLM) announced board changes on November 17, 2025. Po-Jen Hsueh resigned, and Dr. Ya-Chi (Claudia) Huang was appointed, joining the Audit and Nominating and Corporate Governance Committees. The seven-member board now has five independent directors. Dr. Huang’s background includes biotechnology investment experience at Maxpro Ventures and Diamond Biofund, as well as a Ph.D. in Microbiology. Her expertise could benefit Apollomics’ biopharmaceutical development and future financing.
